Page last updated: 2024-11-11

restacorin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

restacorin: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6918035
MeSH IDM0166296

Synonyms (11)

Synonym
tyb-3823
restacorin
gyki 38233
tyb 3823
1-(2,6-dimethylphenyl)-4,4-dimethylaminoguanidine hydrochloride
hydrazinecarboximidamide, 2-(2,6-dimethylphenyl)-n,n-dimethyl-, monohydrochloride
1-(2,6-dimethylphenyl)-4,4-dimethylaminoguanidine hcl
n,n-dimethyl-2-(2,6-dimethylphenyl)hydrazinecarboximidamide monohydrochloride
hydrazinecarboximidamide, n,n-dimethyl-2-(2,6-dimethylphenyl)-, monohydrochloride
DTXSID30143494
2-(2,6-dimethylanilino)-1,1-dimethylguanidine;hydrochloride

Research Excerpts

Overview

Restacorin is a recently developed effective antiarrhythmic agent with primarily class Ic properties.

ExcerptReferenceRelevance
"Restacorin is a recently developed effective antiarrhythmic agent with primarily class Ic properties. "( Restacorin, a new antiarrhythmic drug: a review of its electrophysiologic and hemodynamic properties.
Crinjns, HJ; Jonkman, JH; Kozma, C; Lie, KI; Rabloczky, G; Tuininga, YS, 1994
)
3.17
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (15)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (13.33)18.7374
1990's13 (86.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.30

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.30 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index5.14 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.30)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (6.67%)5.53%
Reviews1 (6.67%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (86.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]